ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.49858
0.00%
Bitcoin
68,064.66
0.50%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cymabay Therapeutics Inc (CBAY)

  7. Cymabay Therapeutics Inc (CBAY) News

CBAY

Cymabay Therapeutics (CBAY)

Cymabay Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CBAY
DateTimeSourceHeadlineSymbolCompany
23/03/202400:18Business WireGilead Sciences Announces Completion of Acquisition of CymaBayNASDAQ:CBAYCymabay Therapeutics Inc
12/03/202400:14Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
08/03/202408:35Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
29/02/202409:01Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
23/02/202422:25Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:CBAYCymabay Therapeutics Inc
17/02/202409:14Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
16/02/202408:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
15/02/202410:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
15/02/202408:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
15/02/202404:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CBAYCymabay Therapeutics Inc
15/02/202401:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
14/02/202408:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
13/02/202409:29Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
13/02/202408:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
13/02/202405:43PR Newswire (US)Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law FirmNASDAQ:CBAYCymabay Therapeutics Inc
13/02/202400:45Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
13/02/202400:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBAYCymabay Therapeutics Inc
07/02/202409:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
02/02/202409:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
31/01/202410:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
30/01/202409:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
27/01/202410:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
27/01/202410:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
27/01/202410:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
27/01/202410:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
27/01/202410:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
27/01/202410:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
27/01/202410:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
27/01/202410:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
27/01/202410:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CBAY

Your Recent History

ASX
XTO
S&P ASX 100
FX
EURAUD
Euro vs AUD
PM
XAUUSD
Gold vs US Dollar
ASX
WDC
Westfield
NYSE
JPM
JP Morgan Chase
ASX
WES
Wesfarmers
NASDAQ
MSFT
Microsoft
FTSE
UKX
FTSE 100
NYSE
KO
Coca Cola
FX
AUDJPY
AUD vs Yen
NYSE
VZ
Verizon Communications
ASX
TLS
Telstra
SPI
SP500
S&P 500
ASX
FMG
Fortescue
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved